We are pleased to announce that the OCT series is extending to Switzerland 2018 to bring innovative and solutions focused content to the DACH biopharmaceutical market. Spinning off from the flagship OCT Europe event this intimate audience of local players allows for focused, lucrative learning and networking on site.

Through in-depth research conducted with local biopharma companies, this event will deliver insight, debate, discussion, presentation and opinion on high priority outsourcing, operations and technology-based themes within the clinical trials space locally.

Key Agenda Highlights 2018
1) Building collaborations with external providers to guarantee the best delivery through innovation. (Gisele Tavares, Procurement – Global Head Alliance Management and Internal Business Partner at Roche)

2) Onstage Interview: Working to foster a reputation in clinical development to partner with large solution providers for trusted timelines and high-quality deliverables – (Dirk Weber, Chief Medical Officer at Cellestia Biotech AG/Aurealis Pharma AG)

3) Considerations in observational research – the importance of long-term partnerships – (Pamela Bacon, Head of Medical Affairs Communications and Operations, Worldwide Markets at Celgene) 

Why must you attend?

OCTDACH brings recognised experts specifically in the DACH region to discuss, collaborate and network with a variety of key service providers as well as other biopharmaceuticals from innovative and collaborative ideas to help overcome challenges.

This event will deliver insights, debates, discussions, presentations and opinion on high priority outsourcing, operations and technology-based themes within the clinical trial space locally.

To learn more about this event, and to register online, visit http://bit.ly/OCTDASH2018

Contact: 
Phone – +44 (0) 207 936 6521
Email – brijesh.patel@arena-international.com